Roivant forms Asian cell therapy ‘vant’, with Medigene’s help

in Greater China, South Korea, and Japan.

AZ makes $6.9bn play for Daiichi Sankyo HER2 drug

The companies will split the costs of bringing the ADC to market and share in global profits, with the exception of Japan where Daiichi Sankyo retains exclusive rights to what it

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

The non-opioid painkiller was registered in Japan under the Tarlige brand name as a treatment for diabetic peripheral neuropathic pain (PNP) and postherpetic neuralgia (PHN) in January, and is a ... Lyrica was approved for fibromyalgia back in 2007,

Success for AZ, setback for Sanofi in type 1 diabetes

AZ’s drug has also been filed in the US, along with Japan, so it will be interesting to see how the FDA handles that marketing application when it delivers a

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]